This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Effects of EXEnatide on Glycemic Control and Weigh...
Clinical trial

Effects of EXEnatide on Glycemic Control and Weight over 26 weeks in Continuous Subcutaneous Insulin Infusion (CSII) Treated Patients with Type 2 Diabetes: a phase 2/3 doUble blind randoMized Placebo-controlled trial.

Read time: 1 mins
Last updated:14th Jan 2010
Change from baseline to 6 months of centrally measured HbA1c
Category Value
Study start date 2010-01-14

View full details